Takahashi K, Imada A
Third Department of Internal Medicine, School of Medicine, Kinki University, Osaka, Japan.
Nihon Jinzo Gakkai Shi. 1991 Jun;33(6):565-74.
As disorders of the defense mechanism in hemodialysis (HD) patients, impairments of cell-mediated immunity have been known, but no agreement has yet been reached as to the function of their polymorphonuclear leukocytes (PMN). Thus this study was undertaken to determine the phagocytic activity and oxygen radicals production of PMN in patients with chronic renal failure (CRF). It was demonstrated that the phagocytic activity of PMN was significantly decreased in HD patients as compared with that in healthy subjects. A significant correlation was also found between phagocytic activity and FcR-positive cells of PMN in HD patients. It suggested that the FcR status of PMN might play an important role with phagocytic activity in HD patients, and the decrease of FcR-positive PMN affects the drop with phagocytic activity. Hydrogen peroxide production of prepared PMN was not significantly different for CRF patients versus healthy subjects. But in whole blood, the enhanced hydrogen peroxide production was observed in all CRF patients. And it was also demonstrated that PMN hydrogen peroxide production become strikingly enhanced when normal PMN was suspended in plasma from CRF patients. When normal renal function was restored by transplantation, hydrogen peroxide production was normalized. These results strongly suggested that the presence of the hydrogen peroxide production enhancing factor in plasma from CRF patients and the enhanced hydrogen peroxide production were specifically associated with renal dysfunction. In plasma of HD patient treated with the EVAL membrane, we measured the hydrogen peroxide production both before and after dialysis. The plasma of postdialysis showed slightly lower hydrogen peroxide production than that of predialysis in most of patients. It was also demonstrated that the plasma from CAPD patients showed a lower hydrogen peroxide production than that from other CRF patients. These results suggested that the hydrogen peroxide production enhancing factor could be considered as one of so called the middle molecules.
作为血液透析(HD)患者防御机制的紊乱,细胞介导免疫的损伤已为人所知,但关于其多形核白细胞(PMN)的功能尚未达成共识。因此,本研究旨在确定慢性肾衰竭(CRF)患者PMN的吞噬活性和氧自由基产生情况。结果表明,与健康受试者相比,HD患者PMN的吞噬活性显著降低。HD患者的吞噬活性与PMN的FcR阳性细胞之间也存在显著相关性。这表明PMN的FcR状态可能在HD患者的吞噬活性中起重要作用,FcR阳性PMN的减少影响吞噬活性的下降。CRF患者与健康受试者制备的PMN的过氧化氢产生没有显著差异。但在全血中,所有CRF患者均观察到过氧化氢产生增强。并且还证明,当正常PMN悬浮于CRF患者的血浆中时,PMN过氧化氢产生显著增强。当通过移植恢复正常肾功能时,过氧化氢产生恢复正常。这些结果强烈表明,CRF患者血浆中存在过氧化氢产生增强因子,且过氧化氢产生增强与肾功能障碍特异性相关。在使用EVAL膜治疗的HD患者血浆中,我们在透析前后测量了过氧化氢产生情况。在大多数患者中,透析后血浆的过氧化氢产生略低于透析前。还证明,持续性非卧床腹膜透析(CAPD)患者的血浆过氧化氢产生低于其他CRF患者。这些结果表明,过氧化氢产生增强因子可被视为所谓的中分子之一。